These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1719814)

  • 1. Human chorionic gonadotrophin and trisomy 18.
    Barkai G; Chaki R; Sochat M; Goldman B
    Am J Med Genet; 1991 Oct; 41(1):52-3. PubMed ID: 1719814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol.
    Heyl PS; Miller W; Canick JA
    Obstet Gynecol; 1990 Dec; 76(6):1025-31. PubMed ID: 1700348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18.
    Summers AM; Huang T; Wyatt PR
    Prenat Diagn; 2002 Mar; 22(3):269-71. PubMed ID: 11920909
    [No Abstract]   [Full Text] [Related]  

  • 7. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-trimester maternal serum analyte levels associated with fetal trisomy 13.
    Saller DN; Canick JA; Blitzer MG; Palomaki GE; Schwartz S; Blakemore KJ; Haddow JE
    Prenat Diagn; 1999 Sep; 19(9):813-6. PubMed ID: 10521837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
    Ashwood ER; Cheng E; Luthy DA
    Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol.
    Hogge WA; Fraer L; Melegari T
    Am J Obstet Gynecol; 2001 Aug; 185(2):289-93. PubMed ID: 11518881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal maternal serum levels of human chorionic gonadotropin free subunits in trisomy 18.
    Ozturk M; Milunsky A; Brambati B; Sachs ES; Miller SL; Wands JR
    Am J Med Genet; 1990 Aug; 36(4):480-3. PubMed ID: 2389806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ; Watt HC
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA; Ying J; Beazoglou T; Egan JF
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
    Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG
    Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second trimester two-step trisomy 18 screening using maternal serum markers.
    Muller F; Sault C; Lemay C; Roussel-Mizon N; Forestier F; Frendo JL;
    Prenat Diagn; 2002 Jul; 22(7):605-8. PubMed ID: 12124697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trisomy 18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result.
    Celentano C; Guanciali-Franchi PE; Liberati M; Prefumo F; Palka G; Rotmensch S
    J Med Screen; 2005; 12(4):203. PubMed ID: 16417699
    [No Abstract]   [Full Text] [Related]  

  • 19. The sensitivity of the trivariate analysis using maternal serum alpha-feto protein, human chorionic gonadotrophin and maternal age in screening for fetal aneuploidy in mothers above the age of 35.
    Anandakumar C; Chew S; Wong YC; Goh VH; Tain CF; Ratnam SS
    J Perinat Med; 1999; 27(3):178-82. PubMed ID: 10503178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum triple analyte screening in pregnancy.
    Graves JC; Miller KE; Sellers AD
    Am Fam Physician; 2002 Mar; 65(5):915-20. PubMed ID: 11898965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.